OR
Orexo AB (publ)
ORXOY · OTC
$1.39 +0.00% (+$0.00)
1M -16.27%
Market Cap 480.3M kr
P/E Ratio -
Div. Yield -
ROE 136.94%
Bulios Fair Price
$0.73
47.5% downside
Current Price
$1.39
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ORXOY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
71 /100
Cheap P/S 3.70x
P/B 1.77x
P/E N/A
Growth
22 /100
Declining Rev. growth 65.37%
Book val. growth 36.15%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 57.96%
Net margin 237.89%
Op. margin 235.08%
Quality
3 /100
Poor ROIC 104.00%
ROE 136.94%
ROA 59.95%
Debt
65 /100
Moderate Debt/Equity 0.04x
Current ratio 1.65x
Int. coverage -5.71x
Stability
36 /100
Moderate Beta 0.85x
Rev. volatility 53.89%
EPS volatility 52.19%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ORXOY
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Nikolaj Sorensen
Employees
74
Headquarters
Uppsala
Upcoming events
22 OCT
Earnings
Upcoming earnings report